BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200807T100000
DTEND;TZID=America/New_York:20200807T150000
DTSTAMP:20260409T044207
CREATED:20200720T163544Z
LAST-MODIFIED:20200720T163544Z
UID:4158-1596794400-1596812400@carb-x.org
SUMMARY:Longitude Prize Sprint Workshop 1 - Navigating MedTech Regulation Pathways in Developed and Emerging Markets
DESCRIPTION:In July 2020\, the Longitude Prize is launching the Longitude Prize Sprint Programme. The Sprint programme is free and will consist of a mix of Sprint Workshops and Sprint 1:1 Expert Support and is perfect for people and teams working in the field of AMR diagnostic test development. The Longitude Prize will be running three Sprint Workshop webinars from July to November 2020. The Sprint Workshops (virtual webinars) are open to all Longitude Prize Competitors\, along with diagnostic test developers who are looking for technical advice and support for regulatory pathways\, finance and investment\, and manufacture and distribution strategies.\n\n\nLongitude Prize Sprint Workshop 1 – Navigating MedTech Regulation Pathways in Developed and Emerging Markets \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMedtech product development and commercialisation for devices and diagnostics is a complex process and has a long gestation period. There are many uncertainties that Medtech product development has to navigate especially during technology development and validation stages of product development as well as being able to meet regulatory standards. Successful navigation of the regulatory maze is important in product development roadmap. \nThere are subtle and distinct variations in regulatory standards for Medtech products across different geographies especially between developed and developing countries. Another layer of complexity is the continuous change in regulatory landscapes both in mature and evolving markets across the world. \nThe workshop (virtual webinar)\, as part of the Longitude Prize Sprint programme\, will draw upon insights from experts in Medtech regulation and address the nuances of regulation in different geographies which will guide Medtech companies in their product development strategies. \n\nTo learn more\, click here. 
URL:https://carb-x.org/event/longitude-prize-sprint-workshop-1-navigating-medtech-regulation-pathways-in-developed-and-emerging-markets/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200824
DTEND;VALUE=DATE:20200829
DTSTAMP:20260409T044207
CREATED:20200214T152647Z
LAST-MODIFIED:20200824T153930Z
UID:3796-1598227200-1598659199@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics
DESCRIPTION:This year’s digital AMR Conference will be an international forum to discuss AMR in the context of COVID-19 and beyond. \nCARB-X speakers include Kevin Outterson\, Executive Director\, Erin Duffy\, Chief of Research and Development\, and Betsy Wonderly Trainor\, Alliance Director. \nThe current global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally. \nTogether with our supporters – among others our major partner\, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry\, SMEs\, start-ups\, academia\, clinics\, investors\, public institutions and policy. Within our digital AMR Conference Week in August\, we want to catch up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market and as a result\, help to establish a post-COVID policy roadmap on AMR. \nFive days of insights and networking for the global AMR community: Each conference day will cover a focus topic with selected LIVE sessions and high-level panels. Additionally\, you will be able to explore scientific poster presentations and participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform which is currently being set up. \n\n\n\n\n\nClick here to view the programme.\nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/biocom-4th-amr-conference-novel-antimicrobials-and-amr-diagnostics/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200825T073000
DTEND;TZID=America/New_York:20200825T090000
DTSTAMP:20260409T044207
CREATED:20200817T131922Z
LAST-MODIFIED:20200819T143135Z
UID:4251-1598340600-1598346000@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: Business models | The AMR company of the future – Which route to success
DESCRIPTION:Moderator: \n\nErin Duffy – Chief of Research & Development\, CARB-X\n\nSpeakers: \n\nJonathan Butcher – Head of Business Development\, BioVersys AG\nCherif Bousselham – Senior Vice President\, Head of Sales\, EMEA\, Accelerate Diagnostics Inc.\nJean-Pierre Paccaud – Director of Business Development and Corporate Strategy\, GARDP\nKenneth Bradley – Global Head\, Infectious Disease Discovery\, Roche
URL:https://carb-x.org/event/biocom-4th-amr-conference-business-models-the-amr-company-of-the-future-which-route-to-success/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200825T091500
DTEND;TZID=America/New_York:20200825T101500
DTSTAMP:20260409T044207
CREATED:20200817T131812Z
LAST-MODIFIED:20200819T143409Z
UID:4250-1598346900-1598350500@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: Business models in AMR | How to develop strategic decisions in a challenging and global AMR market
DESCRIPTION:Moderator:  \n\nGökhan Batur – CEO\, Polyphor Ltd\n\nSpeakers: \n\nPeter Beyer – Senior Advisor Department of Essential Medicines & Health Products\, WHO\nErin Duffy – Chief of Research & Development\, CARB-X\nHolger Zimmermann – CEO\, AiCuris
URL:https://carb-x.org/event/biocom-4th-amr-conference-sme-approach-how-to-develop-strategic-decisions-in-a-challenging-and-global-amr-market/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200825T103000
DTEND;TZID=America/New_York:20200825T114500
DTSTAMP:20260409T044207
CREATED:20200817T132110Z
LAST-MODIFIED:20200819T143706Z
UID:4254-1598351400-1598355900@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: AMR pull incentives | Will COVID-19 speed up or slow down implementation?
DESCRIPTION:Moderator:  \n\nKathy Talkington\, Director Health Programs\, Pew Charitable Trust\n\nSpeakers: \n\nColm Leonard – Clinical Advisor/Consultant\, NICE\nKevin Outterson – Professor of Law & Executive Director\, CARB-X\nElmar Nimmesgern – Secretariat Lead\, Global AMR R&D Hub\nDaniel Berman – Lead of the Global Health Team\, Longitude Prize / Nesta
URL:https://carb-x.org/event/biocom-4th-amr-conference-amr-pull-incentives-will-covid-19-speed-up-or-slow-down-implementation/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200827
DTEND;VALUE=DATE:20200829
DTSTAMP:20260409T044207
CREATED:20200819T141417Z
LAST-MODIFIED:20200824T153935Z
UID:4279-1598486400-1598659199@carb-x.org
SUMMARY:Bacteriophage Therapy Summit
DESCRIPTION:As the scientific community search for alternatives to broad spectrum antibiotics\, phage therapy has re-emerged as a viable solution to tackle the global health challenge of anti-microbial resistance. \nAs such\, the 2nd Bacteriophage Therapy Summit returns digitally as a dedicated platform for leaders in industry and academia to accelerate the discovery and translation of bacteriophage research into targeted therapeutics that demonstrate clinically significant results. \nWith a heavy translationally focused agenda including how to overcome bacterial resistance scaling-up manufacturing and showing clinical efficacy this is your opportunity to join your peers to strengthen your product development pipelines and forge collaborations to unlock the full potential of bacteriophage therapeutics. \nView the full event guide for further details on speakers\, content and how to join those who paving the way for bacteriophage-based therapeutics!
URL:https://carb-x.org/event/bacteriophage-therapy-summit-2/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200827T060000
DTEND;TZID=America/New_York:20200827T070000
DTSTAMP:20260409T044207
CREATED:20200817T132156Z
LAST-MODIFIED:20200824T153824Z
UID:4255-1598508000-1598511600@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: SME campus (Part II) | Focus on diagnostics
DESCRIPTION:Moderator: \n\nBetsy Wonderly Trainor\, Alliance Director\, CARB-X\n\nSpeakers: \n\nPeter Haug – CFO & Co-Founder\, Head of Business Development & Licensing\, Noscendo GmbH\nPiotr Gastrecki – CTO\, ScopeFluidics\nRosemarie Preyer – GenID GmbH
URL:https://carb-x.org/event/biocom-4th-amr-conference-sme-campus-part-ii-focus-on-diagnostics/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR